T
Thomas Abeel
Researcher at Delft University of Technology
Publications - 96
Citations - 10940
Thomas Abeel is an academic researcher from Delft University of Technology. The author has contributed to research in topics: Genome & Gene. The author has an hindex of 27, co-authored 81 publications receiving 8039 citations. Previous affiliations of Thomas Abeel include Ghent University & Flanders Institute for Biotechnology.
Papers
More filters
Journal ArticleDOI
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal
Keira A. Cohen,Thomas Abeel,Abigail Manson McGuire,Christopher A. Desjardins,Vanisha Munsamy,Terrance Shea,Bruce J. Walker,Nonkqubela Bantubani,Deepak V. Almeida,Lucia Alvarado,Sinéad B. Chapman,Nomonde R. Mvelase,Eamon Y. Duffy,Michael Fitzgerald,Pamla Govender,Sharvari Gujja,Susanna Hamilton,Clinton Howarth,Jeffrey D. Larimer,Kashmeel Maharaj,Matthew D. Pearson,Margaret Priest,Qiandong Zeng,Nesri Padayatchi,Jacques H. Grosset,Sarah Young,Jennifer R. Wortman,Koleka Mlisana,Max R. O'Donnell,Bruce W. Birren,William R. Bishai,Alexander S. Pym,Ashlee M. Earl +32 more
TL;DR: The first whole genome-based analysis of the emergence of drug resistance among clinical isolates of M. tuberculosis shows that the ancestral precursor of the LAM4 XDR outbreak strain in Tugela Ferry gained mutations to first-line drugs at the beginning of the antibiotic era.
Journal ArticleDOI
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance
Abigail L. Manson,Keira A. Cohen,Keira A. Cohen,Thomas Abeel,Thomas Abeel,Christopher A. Desjardins,Derek T. Armstrong,Clifton E. Barry,Jeannette Brand,Sinéad B. Chapman,Sang Nae Cho,Andrei Gabrielian,James Gomez,Andreea M. Jodals,Moses Joloba,P. Jureen,Jong Seok Lee,Lesibana Anthony Malinga,Mamoudou Maiga,Dale Nordenberg,Ecaterina Noroc,Elena Romancenco,Alex N. Salazar,Alex N. Salazar,Willy Ssengooba,Ali Akbar Velayati,Kathryn Winglee,Aksana Zalutskaya,Laura E. Via,Gail H. Cassell,Susan E. Dorman,Jerrold J. Ellner,Parissa Farnia,James E. Galagan,James E. Galagan,Alex Rosenthal,Valeriu Crudu,Daniela Homorodean,Po-Ren Hsueh,Sujatha Narayanan,Alexander S. Pym,Alena Skrahina,Soumya Swaminathan,Martie van der Walt,David Alland,William R. Bishai,Ted Cohen,Ted Cohen,Sven Hoffner,Bruce W. Birren,Ashlee M. Earl +50 more
TL;DR: Molecular diagnostics that include markers for rifampicin resistance alone will be insufficient to identify pre-MDR strains, and incorporation of knowledge of polymorphisms that occur before the emergence of multidrug resistance, particularly katG p.Ser315Thr, into molecular diagnostics should enable targeted treatment of patients with pre-mDR-TB to prevent further development of MDR- TB.
Journal ArticleDOI
Computational pan-genomics: status, promises and challenges.
Tobias Marschall,Manja Marz,Manja Marz,Thomas Abeel,Louis Dijkstra,Bas E. Dutilh,Ali Ghaffaari,Ali Ghaffaari,Paul Kersey,Wigard P. Kloosterman,Veli Mäkinen,Adam M. Novak,Benedict Paten,David Porubsky,Eric Rivals,Can Alkan,Jasmijn A. Baaijens,Paul I.W. de Bakker,Valentina Boeva,Raoul J. P. Bonnal,Francesca Chiaromonte,Rayan Chikhi,Francesca D. Ciccarelli,Robin Cijvat,Erwin Datema,Cornelia M. van Duijn,Evan E. Eichler,Evan E. Eichler,Corinna Ernst,Eleazar Eskin,Erik Garrison,Mohammed El-Kebir,Gunnar W. Klau,Jan O. Korbel,Eric-Wubbo Lameijer,Benjamin Langmead,Marcel Martin,Paul Medvedev,John C. Mu,Pieter B. Neerincx,Klaasjan G. Ouwens,Pierre Peterlongo,Nadia Pisanti,Sven Rahmann,Ben Raphael,Knut Reinert,Dick de Ridder,Jeroen de Ridder,Matthias Schlesner,Ole Schulz-Trieglaff,Ashley D. Sanders,Siavash Sheikhizadeh,Carl Shneider,Sandra Smit,Daniel Valenzuela,Jiayin Wang,Lodewyk F. A. Wessels,Y. Zhang,Victor Guryev,Fabio Vandin,Kai Ye,Alexander Schönhuth +61 more
TL;DR: Already available approaches to construct and use pan-genomes are examined, the potential benefits of future technologies and methodologies are discussed, and open challenges from the vantage point of the above-mentioned biological disciplines are reviewed.
Journal ArticleDOI
Generic eukaryotic core promoter prediction using structural features of DNA
TL;DR: A novel approach for predicting promoters in whole-genome sequences by using large-scale structural properties of DNA that requires no training, is applicable to many eukaryotic genomes, and performs extremely well in comparison with the best available promoter prediction programs.
Journal ArticleDOI
ANGUSTIFOLIA3 Binds to SWI/SNF Chromatin Remodeling Complexes to Regulate Transcription during Arabidopsis Leaf Development
Liesbeth Vercruyssen,Aurine Verkest,Nathalie Gonzalez,Ken S. Heyndrickx,Dominique Eeckhout,Soon-Ki Han,Teddy Jégu,Rafal Archacki,Jelle Van Leene,Megan Andriankaja,Stefanie De Bodt,Thomas Abeel,Frederik Coppens,Stijn Dhondt,Liesbeth De Milde,Mattias Vermeersch,Katrien Maleux,Kris Gevaert,Andrzej Jerzmanowski,Andrzej Jerzmanowski,Moussa Benhamed,Doris Wagner,Klaas Vandepoele,Geert De Jaeger,Dirk Inzé +24 more
TL;DR: The data indicate that AN3 associates with chromatin remodelers to regulate transcription, and place the SWI/SNF-AN3 module as a major player at the transition from cell proliferation to cell differentiation in a developing leaf.